Low-dose atropine EIKANCE secures first myopia TGA approval
The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children ...
Tag: Aspen
Glaucoma treatments change hands under pharmaceutical merger
A proposed merger between two pharmaceutical companies that compete in the glaucoma treatment markets has been given the green light ...